Evidence map›Paper›PMID 12208869›Full record

ArticleThe Journal of clinical investigation2002

Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death.

Min Li-Weber, Markus A Weigand, Marco Giaisi, Dorothee Süss, Monika K Treiber, Sven Baumann, Elena Ritsou, Raoul Breitkreutz, Peter H Krammer

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. T cells and reactive oxygen species.Journal of biomedical science · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Min Li-WeberTumor Immunology G0300, German Cancer Research Center, Heidelberg, Germany.
Markus A Weigand
Marco Giaisi
Dorothee Süss
Monika K Treiber
Sven Baumann
Elena Ritsou
Raoul Breitkreutz
Peter H Krammer
German Cancer Research Center · DEHeidelberg University · DEBipar · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptosis is a morphologically distinct form of cell death involved in many physiological and pathological processes. Expression of the CD95 (APO-1/Fas) ligand (CD95L) is critically involved in activation-induced cell death (AICD) of activated T cells. Here we show that the natural free radical scavenger vitamin E suppresses the activity of the transcription factors NF-kappa B and AP-1, thus blocking expression of CD95L and preventing T cell AICD. Since AICD is a major cause of T cell depletion in AIDS, we examined 35 HIV-1-positive individuals and found that their T cells are more susceptible to AICD than are T cells isolated from healthy controls. Administration of vitamin E suppresses CD95L mRNA expression and protects T cells of HIV-1-infected individuals from CD95-mediated apoptosis. This evidence that vitamin E can affect T cell survival may merit further clinical investigation.

Indexed as

AdultCell DeathCell NucleusCells, CulturedCell SurvivalDose-Response Relationship, DrugFas Ligand ProteinFemaleHIV SeropositivityHumansJurkat CellsLuciferasesLymphocyte ActivationMaleMembrane GlycoproteinsMiddle AgedFASLG protein, humanFas Ligand ProteinLuciferasesMembrane GlycoproteinsNF-kappa BRNA, MessengerTranscription Factor AP-1Vitamin E

Identifiers

PMID12208869
PMCPMC151103
OpenAlexW1977216892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.